Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”

키워드

참고문헌 (15)

1. Bo Hyun Kim, "Surveillance for hepatocellular carcinoma: It is time to move forward", Clinical and Molecular Hepatology, 28(4), pp.810~813 (2022), 대한간학회
2. Won Sohn, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clinical and Molecular Hepatology, 28(4), pp.851~863 (2022), 대한간학회
3. European Association for the Study of the Liver, "EASL clinical practice guidelines : management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
4. Marrero JA, "Diagnosis, staging, and management of hepatocellular carcinoma : 2018 practice guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
5. Liaw YF, "Lamivudine for patients with chronic hepatitis B and advanced liver disease", N Engl J Med, 351, pp.1521~1531 (2004)
6. Hyung Joon Yim, "Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop", Clinical and Molecular Hepatology, 26(4), pp.411~429 (2020), 대한간학회[DOI]
7. Cho JY, "Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease", Gut, 63, pp.1943~1950 (2014)
8. Chang TT, "Longterm entecavir therapy results in the reversal of fibrosis", cirrhosis and continued histological improvement in patients with chronic hepatitis B, 2010, pp.52, 886~893
9. Marcellin P, "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B : a 5-year open-label follow-up study", Lancet, 381, pp.468~475 (2013)
10. Omar Alshuwaykh, "Current and future strategies for the treatment of chronic hepatitis C", Clinical and Molecular Hepatology, 27(2), pp.246~256 (2021), 대한간학회[DOI]
11. Mueller PP, "Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication", J Hepatol, 77, pp.55~62 (2022)
12. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
13. Bianco C, "Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores", J Hepatol, 74, pp.775~782 (2021)
14. Jamak Modaresi Esfeh, "Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard", Clinical and Molecular Hepatology, 26(1), pp.54~59 (2020), 대한간학회
15. Singal A, "Meta-analysis : surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis", Aliment Pharmacol Ther, 30, pp.37~47 (2009)

관련 논문AI추천